Taper diabetes drugs with the 5:2 diet

First study into patients with diabetes on a fasting diet

The first study to taper hypoglycaemic drug levels for patients with type 2 diabetes who are on an intermittent fasting regimen has shown lower than expected hypoglycaemic events.


Designed to see whether people with type 2 diabetes on glucose-lowering medications could safely implement the popular 5:2 intermittent fasting diet, where food intake is calorie-restricted just two days a week, the New Zealand study enrolled 37 patients.

Despite reducing glucose-lowering drugs on fasting days, hypoglycaemic events were twice as likely on days when just